TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Devonian Health Group ( (TSE:GSD) ) is now available.
Devonian Health Group Inc. announced its participation in the ThinkEquity Conference in New York, where CEO Dr. André Boulet will present to institutional investors and analysts. Additionally, the company closed a non-brokered private placement, raising $334,500.33 to support working capital and research and development, subject to TSX Venture Exchange approval.
More about Devonian Health Group
Devonian Health Group Inc. is a biopharmaceutical company focused on developing innovative prescription drugs, particularly targeting inflammatory diseases.
Average Trading Volume: 21,953
Technical Sentiment Signal: Sell
Current Market Cap: C$37.06M
For detailed information about GSD stock, go to TipRanks’ Stock Analysis page.